• EAACI
  • Events
  • Professionals
  • Patients
  • News
Become a Member
Become a Member

EAACI Congress 2025 Back

13 - 16 June 2025 Glasgow, United Kingdom

Antonella Cianferoni

United States of America

Antonella Cianferoni

xx

Sessions

Friday 13 Jun
14:15 - 14:45 Management of Eosinophilic Esophagitis as a side effect of food oral immunotherapy
16:45 - 18:15
IWS5 Exploring the clinical management of Eosinophilic Esophagitis Interactive Workshop Forth
Saturday 14 Jun
16:45 - 18:15
FT12 Early-life influences on allergy and immune development Flash Talks Dochart 1
Sunday 15 Jun
09:24 - 09:36 Dupilumab Is Efficacious in Children Aged 1–11 Years Weighing ≥15 kg With Eosinophilic Esophagitis Irrespective of Individual Atopic Comorbidities: 16-Week Results From the Phase 3 EoE KIDS Study
Dupilumab improves multiple histopathologic features of eosinophilic esophagitis over 52 weeks: Post hoc analysis of the phase 3 LIBERTY EoE TREET study
×